Keywords
Fractures
Bone
Frailty
Geriatrics
Osteoporosis
Mortality
How to Cite
Abstract
Backgroung: Secondary fracture prevention programs (SFPPs) are designed to identify and treat individuals with fragility fractures, to prevent future fractures.
Purpose: To describe the follow-up in falls, refractures and mortality in the PPSF at the San José Hospital (HSJ) in Bogotá, for one year.
Methodology: Descriptive cohort study carried out in patients with fragility fractures of the PPSF at the HSJ between January/2022 and August/2023 with one year of follow-up. The Key Performance Indicators (KPI) established by the IOF were analyzed.
Results: 118 patients with a mean age of 79 years (74.6% women), of whom 103 had one year of telephone follow-up. The most frequent fracture was hip (66%). Antiosteoporosis treatment was prescribed to 87% of patients (n = 103) before hospital discharge, of which 58.2% (n = 60) started at 4 months, 54.4% (56) and 52.4% (54) continued it at 6 and 12 months post-fracture, respectively. Falls were recorded in 13.6% (n = 14), refracture in 1.9% (n = 2), and death in 11.6% (n = 12).
Discussion: Although PPSFs reduce the treatment gap in patients with fragility fracture, there are few studies evaluating refracture. In the HSJ, adequate performance is observed in the initiation and continuity of treatment, with low rates of falls, refractures, and mortality.
Conclusion: PPSF prevents refractures through timely treatment and follow-up, so its implementation will reduce morbidity and mortality associated with osteoporosis.
References
Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C. The epidemiology of osteoporosis. Br Med Bull. 2020;133(1):105-17. https://doi.org/10.1093/bmb/ldaa005
Khan AA, Slart RHJA, Dalal SA, Bock O, Carey JJ, Camacho P, et al. Osteoporotic fractures: diagnosis, evaluation, and significance from the international working group on DXA best practices. Mayo Clin Proc. 2024;99(7):1127-41. https://doi.org/10.1016/j.mayocp.2024.01.011
van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001;29(6):517-22. https://doi.org/10.1016/s8756-3282(01)00614-7
Golob AL, Laya MB. Osteoporosis: screening, prevention, and management. Med Clin North Am. 2015;99(3):587-606. https://doi.org/10.1016/j.mcna.2015.01.010
Kanis JA, Johansson H, Odén A, Harvey NC, Gudnason V, Sanders KM, et al. Characteristics of recurrent fractures. Osteoporos Int. 2018;29(8):1747-57. https://doi.org/10.1007/s00198-018-4502-0
Kanis JA, Johansson H, McCloskey EV, Liu E, Åkesson KE, Anderson FA, et al. Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX. Osteoporos Int. 2023;34(12):2027-2045. https://doi.org/10.1007/s00198-023-06870-z
Latam Audit. Epidemiologia, costo e impacto de la osteoporosis y las fracturas por fragilidad [internet]. IOF; 2021. [citado 2025 en. 19]. https://www.osteoporosis.foundation/sites/iofbonehealth/files/2022-08/LATAM%20Audit%202021%20-%20FINAL.pdf
Åkesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, et al. Capture the Fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013;24(8):2135-52. https://doi.org/10.1007/s00198-013-2348-z
Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum. 2006;35(5):293-305. https://doi.org/10.1016/j.semarthrit.2005.11.001
McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int. 2003;14(12):1028-34. https://doi.org/10.1007/s00198-003-1507-z
Medina Orjuela A, Rosero Olarte O, Rueda Plata PN, Sánchez Escobar F, Chalem Choueka M, González Reyes MA, et al. II Consenso Colombiano para el Manejo de la Osteoporosis Posmenopáusica. Rev Colomb Reumatol. 2018;25(3):184-210. https://doi.org/10.1016/j.rcreu.2018.02.006
Javaid MK, Sami A, Lems W, Mitchell P, Thomas T, Singer A, et al. A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int. 2020;31(7):1193-204. https://doi.org/10.1007/s00198-020-05377-1
Clark P, Méndez-Sánchez L, Ramírez-García S, Sánchez-García S, Medina A, Medina Chávez JH. Incidence of secondary fractures after implementation of different models of FLS secondary prevention programs: scoping review. Arch Med Res. 2025;56(2):103121. https://doi.org/10.1016/j.arcmed.2024.103121
International Osteoporosis Foundation. Map of Best Practice [internet]. Capture the Fracture; 2023. [citado 2025 en. 19]. https://www.capturethefracture.org/map-of-best-practice
Patel R, Judge A, Johansen A, Javaid MK, Griffin XL, Chesser T, et al. Following hip fracture, hospital organizational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study. J Bone Miner Res. 2024;39(8):1071-82. https://doi.org/10.1093/jbmr/zjae100
Medina A, Altamar G, Fernández-Ávila DG, Leal J, Castro E, Rivera A, et al. Clinical characteristics and impact of treatment gap of fragility fractures in Colombia: experience of 10 Fracture Liaison Services (FLS). J Gerontol Geriatr. 2021;69(3):147-54. https://doi.org/10.36150/2499-6564-N307
Olarte CM, López AM, Tihanyi Feldman J, Libos Zabala A, Morales DC, Patiño AF, et al. Impact of a secondary prevention program for fragility fractures at the Orthogeriatric Clinical Care Center at the Fundación Santa Fe de Bogotá, 2014-2020. Geriatr Orthop Surg Rehabil. 2022;13:21514593221118182. https://doi.org/10.1177/21514593221118182
Valladales-Restrepo LF, Castro-Osorio EE, Ramírez-Osorio J, Echeverry-Martinez LF, Sánchez-Ríos V, Gaviria-Mendoza A, et al. Characterization and effectiveness of a Fracture Liaison Services program in Colombia. Arch Osteoporos. 2023;18(1):124. https://doi.org/10.1007/s11657-023-01331-w
Morin S, Lix LM, Azimaee M, Metge C, Caetano P, Leslie WD. Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int. 2011;22(9):2439-48. https://doi.org/10.1007/s00198-010-1480-2
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353(9156):878-82. https://doi.org/10.1016/s0140-6736(98)09075-8
Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633-50. https://doi.org/10.1007/s00198-009-0920-3
Che H, Breuil V, Cortet B, Paccou J, Thomas T, Chapuis L, et al. Vertebral fractures cascade: potential causes and risk factors. Osteoporos Int. 2019;30(3):555-63. https://doi.org/10.1007/s00198-018-4793-1
Clark P, Cons-Molina F, Deleze M, Ragi S, Haddock L, Zanchetta JR, et al. The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int. 2009;20(2):275-82. https://doi.org/10.1007/s00198-008-0657-4
Medina A, Rivera A, Bautista K, Alvarado A. Características clínicas de los pacientes con fracturas por fragilidad. Reperto Med Cir. 2018;27(1):30-5. https://doi.org/10.31260/RepertMedCir.v27.n1.2018.129
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104(5):1595-1622. https://doi.org/10.1210/jc.2019-00221
Garcia Perlaza J, Guerrero Regino EA, Terront Lozano A, Molina JF, Perez C, Jannaut MJ, et al. Costos de las fracturas en mujeres con osteoporosis en Colombia. Acta Med Col. 2014;39(1):46-56. https://doi.org/10.36104/amc.2014.89
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Revista Colombiana de Endocrinología, Diabetes & Metabolismo